Saggar 2011.

Trial name or title	Intraoperative versus postoperative thymoglobulin in lung transplantation
Methods	Prospective single centre double‐blind RCT
Participants	All patients eligible for bilateral lung transplantation between the ages of 18 to 65 years
Interventions	Intraoperative dosing of Thymoglobulin followed by 3 additional postoperative doses (the first of these 3 postoperative doses will be placebo) versus 3 postoperative doses of Thymoglobulin (the intraoperative dose will be placebo)
Outcomes	Primary graft dysfunction assessed at 24 hours and 48 hours post‐transplant
Starting date	January 2006
Contact information	Rajan Saggar MD, Department of Pulmonology and Critical Care at David Geffen School of Medicine at UCLA
Notes	No results identified